MedTrace Logo

Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients

NCT00753493 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-07-18

No results posted yet for this study

Summary

The aims of this study are to determine, in adult patients on maintenance topiramate therapy, the steady-state pharmacokinetics and safety of orally and intravenously administered topiramate.

Conditions

Interventions

DRUG

intravenous topiramate

Single 25 mg IV dose given in addition to subject's normal morning dose of topiramate

Sponsors & Collaborators

Principal Investigators

  • James C Cloyd, PharmD · University of Minnesota

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00753493 on ClinicalTrials.gov